Clinical Trial Update: Effect of Recombinant Human Growth Hormone (rhGH) on Abdominal Fat and Cardiovascular Risk in Obese Girls [Phase 2]

View source ↗

Summary

Phase 2 trial update evaluating recombinant human growth hormone (rhGH) on abdominal fat and cardiovascular risk in obese girls has completed with results poste…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Obesity

Drugs mentioned

• Recombinant human growth hormone (somatropin)

Snippet

Sponsor: Massachusetts General Hospital | Conditions: Obesity | Phase 2 | Status: COMPLETED | Results posted: 2014-07-21